U.S. markets open in 4 hours 8 minutes
  • S&P Futures

    4,157.50
    -34.00 (-0.81%)
     
  • Dow Futures

    33,977.00
    -120.00 (-0.35%)
     
  • Nasdaq Futures

    12,653.50
    -193.25 (-1.50%)
     
  • Russell 2000 Futures

    2,005.70
    -2.20 (-0.11%)
     
  • Crude Oil

    75.87
    -0.01 (-0.01%)
     
  • Gold

    1,924.80
    -6.00 (-0.31%)
     
  • Silver

    23.50
    -0.11 (-0.47%)
     
  • EUR/USD

    1.0930
    +0.0019 (+0.17%)
     
  • 10-Yr Bond

    3.3960
    0.0000 (0.00%)
     
  • Vix

    18.47
    +0.60 (+3.36%)
     
  • GBP/USD

    1.2238
    +0.0009 (+0.08%)
     
  • USD/JPY

    128.5440
    -0.0600 (-0.05%)
     
  • BTC-USD

    23,416.07
    -401.38 (-1.69%)
     
  • CMC Crypto 200

    534.66
    -10.66 (-1.95%)
     
  • FTSE 100

    7,838.51
    +18.35 (+0.23%)
     
  • Nikkei 225

    27,509.46
    +107.41 (+0.39%)
     

Brighthouse Financial Announces Third Quarter 2022 Results

  • Estimated combined risk-based capital ("RBC") ratio between 450% and 470%; holding company liquid assets of $1.1 billion

  • The company repurchased $447 million of its common stock year-to-date through November 3, 2022

  • Annuity sales increased 58% over the third quarter of 2021 and 50% sequentially

  • Life sales decreased 30% over the third quarter of 2021 and were flat sequentially

  • Third quarter 2022 net loss available to shareholders of $702 million, or $9.82 per diluted share

  • Third quarter 2022 adjusted loss, less notable items*, of $3 million, or $0.04 per diluted share

CHARLOTTE, N.C., November 07, 2022--(BUSINESS WIRE)--Brighthouse Financial, Inc. ("Brighthouse Financial" or the "company") (Nasdaq: BHF) announced today its financial results for the third quarter ended September 30, 2022.

Third Quarter 2022 Results

The company reported a net loss available to shareholders of $702 million in the third quarter of 2022, or $9.82 per diluted share, compared with net income available to shareholders of $361 million in the third quarter of 2021. During the quarter, as a result of market performance, the value of our hedges decreased, as expected. Due to being accounted for as insurance liabilities as required under U.S. GAAP accounting, certain corresponding liabilities are less sensitive to market movements and, therefore, did not fully offset the decrease in the value of our hedges.

Additionally, in the third quarter of 2022, the company completed its annual actuarial review where it reviews its long-term assumptions. As part of this review, the company increased its long-term mean reversion interest rate assumption for the 10-year U.S. Treasury from 3.00% to 3.50%. As a result of the 2022 annual actuarial review, the net favorable impact to net income was $4 million, compared with a net unfavorable impact of $116 million as a result of the 2021 annual actuarial review.

The company ended the third quarter of 2022 with common stockholders' equity ("book value") of $4.1 billion, or $58.73 per common share, and book value, excluding accumulated other comprehensive income ("AOCI") of $10.8 billion, or $153.47 per common share.

For the third quarter of 2022, the company reported adjusted earnings* of $97 million, or $1.35 per diluted share, compared with adjusted earnings of $450 million, or $5.41 per diluted share, in the third quarter of 2021.

___________

* Information regarding the non-GAAP and other financial measures included in this news release and a reconciliation of such non-GAAP financial measures to the most directly comparable GAAP measures are provided in the Non-GAAP and Other Financial Disclosures discussion below, as well as in the tables that accompany this news release and/or the Third Quarter 2022 Brighthouse Financial, Inc. Financial Supplement and/or the Third Quarter 2022 Brighthouse Financial, Inc. Earnings Call Presentation (which are available on the Brighthouse Financial Investor Relations webpage at http://investor.brighthousefinancial.com). Additional information regarding notable items can be found on the last page of this news release.

Adjusted earnings for the quarter reflected $100 million of net favorable notable items, or $1.39 per diluted share, including:

  • $117 million net favorable impact related to actuarial items, including the annual actuarial review, and

  • $17 million unfavorable impact for establishment costs related to planned technology and other expenses associated with the company's separation from its former parent company.

Corporate expenses in the third quarter of 2022 were $217 million, up from $201 million in the second quarter of 2022, both on a pre-tax basis.

Annuity sales increased 58% quarter-over-quarter and 50% sequentially, driven by fixed deferred annuities. Life sales decreased 30% quarter-over-quarter and were flat sequentially, as a result of the recent macroeconomic headwinds.

During the third quarter of 2022, the company repurchased $136 million of its common stock, with an additional $52 million of its common stock repurchased, on a trade date basis, through November 3, 2022.

"In the third quarter of 2022, Brighthouse Financial maintained balance sheet strength, reported strong annuity sales and returned additional capital to shareholders through repurchasing more of our common stock, reflecting the continued execution of our focused strategy," said Eric Steigerwalt, president and CEO, Brighthouse Financial. "Regarding our sales results, I could not be prouder of our record annuity sales of $3.7 billion, as our strong and diverse product suite continues to meet the evolving needs of our clients."

Key Metrics (Unaudited, dollars in millions except share and per share amounts)

As of or For the Three Months Ended

September 30, 2022

September 30, 2021

Total

Per share

Total

Per share

Net income (loss) available to shareholders (1)

$(702)

$(9.82)

$361

$4.34

Adjusted earnings (1)

$97

$1.35

$450

$5.41

Adjusted earnings, less notable items (1)

$(3)

$(0.04)

$514

$6.17

Weighted average common shares outstanding - diluted (1)

71,959,380

N/A

83,244,987

N/A

Book value

$4,115

$58.73

$14,671

$181.23

Book value, excluding AOCI

$10,752

$153.47

$10,381

$128.24

Ending common shares outstanding

70,060,560

N/A

80,952,682

N/A

(1) Per share amounts are on a diluted basis and may not recalculate due to rounding. For loss periods, dilutive shares were not included in the calculation as inclusion of such shares would have an anti-dilutive effect. See Non-GAAP and Other Financial Disclosures discussion in this news release.

Results by Segment and Corporate & Other (Unaudited, in millions)

For the Three Months Ended

ADJUSTED EARNINGS

September 30,

2022

June 30,

2022

September 30,

2021

Annuities

$125

$204

$385

Life (1)

$(7)

$23

$110

Run-off (1)

$(21)

$(164)

$38

Corporate & Other (1)

$—

$(39)

$(83)

(1) The company uses the term "adjusted loss" throughout this news release to refer to negative adjusted earnings values.

Sales (Unaudited, in millions)

For the Three Months Ended

September 30,

2022

June 30,

2022

September 30,

2021

Annuities (1)

$3,721

$2,486

$2,362

Life

$19

$19

$27

(1) Annuities sales include sales of a fixed index annuity product, which represents 100% of gross sales on directly written business and the proportion of assumed gross sales under reinsurance agreements. Sales of this product were $213 million for the third quarter of 2022, $206 million for the second quarter of 2022 and $198 million for the third quarter of 2021.

Annuities

Adjusted earnings in the Annuities segment were $125 million in the current quarter, compared with adjusted earnings of $385 million in the third quarter of 2021 and adjusted earnings of $204 million in the second quarter of 2022.

The current quarter included a $45 million unfavorable notable item and the third quarter of 2021 included a $42 million favorable notable item, both related to the annual actuarial review completed in the respective quarters. The second quarter of 2022 included a $14 million unfavorable notable item related to Shield Level annuities model refinements.

On a quarter-over-quarter basis, adjusted earnings, less notable items, reflect lower fees, higher reserves and higher deferred acquisition costs ("DAC") amortization, partially offset by lower expenses. On a sequential basis, adjusted earnings, less notable items, reflect lower fees and higher reserves, partially offset by lower DAC amortization.

As mentioned above, annuity sales increased 58% quarter-over-quarter and 50% sequentially, driven by fixed deferred annuities.

Life

The Life segment had an adjusted loss of $7 million in the current quarter, compared with adjusted earnings of $110 million in the third quarter of 2021 and adjusted earnings of $23 million in the second quarter of 2022.

The current quarter included a $5 million unfavorable notable item and the third quarter of 2021 included a $3 million favorable notable item, both related to the annual actuarial review completed in the respective quarters. The second quarter of 2022 included a $2 million unfavorable item related to new reinsurance agreements.

On a quarter-over-quarter basis, the adjusted loss, less notable items, reflects lower net investment income and a lower underwriting margin. On a sequential basis, the adjusted loss, less notable items, reflects lower net investment income and higher expenses, partially offset by lower DAC amortization.

As mentioned above, life sales decreased 30% quarter-over-quarter and were flat sequentially, as a result of the recent macroeconomic headwinds.

Run-off

The Run-off segment had an adjusted loss of $21 million in the current quarter, compared with adjusted earnings of $38 million in the third quarter of 2021 and an adjusted loss of $164 million in the second quarter of 2022.

The current quarter included a $128 million favorable notable item and the third quarter of 2021 included an $89 million unfavorable notable item, both related to the annual actuarial review completed in the respective quarters. The second quarter of 2022 included $198 million of unfavorable notable items related to a settlement of a reinsurance matter, as well as new reinsurance agreements.

On a quarter-over-quarter basis, the adjusted loss, less notable items, reflects lower net investment income and a lower underwriting margin. On a sequential basis, the adjusted loss, less notable items, reflects lower net investment income, a lower underwriting margin and higher expenses.

Corporate & Other

Corporate & Other had breakeven adjusted earnings in the current quarter, compared with an adjusted loss of $83 million in the third quarter of 2021 and an adjusted loss of $39 million in the second quarter of 2022.

The current quarter included $22 million of net favorable notable items related to an actuarial item, partially offset by establishment costs. The third quarter of 2021 included a $20 million unfavorable notable item and the second quarter of 2022 included a $9 million unfavorable notable item, both related to establishment costs in the respective quarters.

On a quarter-over-quarter basis, the adjusted loss, less notable items, reflects higher net investment income. On a sequential basis, the adjusted loss, less notable items, reflects higher net investment income and lower expenses, partially offset by a lower tax benefit.

Net Investment Income and Adjusted Net Investment Income (Unaudited, in millions)

For the Three Months Ended

September 30,

2022

June 30,

2022

September 30,

2021

Net investment income

$877

$1,061

$1,281

Adjusted net investment income

$900

$1,070

$1,287

Net Investment Income

Net investment income was $877 million and adjusted net investment income* was $900 million in the current quarter. On a quarter-over-quarter basis, adjusted net investment income decreased $387 million and on a sequential basis decreased $170 million. The quarter-over-quarter and sequential results were primarily driven by lower alternative investment income, partially offset by asset growth.

The net investment income yield was 3.20% during the quarter.

Statutory Capital and Liquidity (Unaudited, in billions)

As of

September 30,

2022 (1)

June 30,

2022

September 30,

2021

Statutory combined total adjusted capital

$8.0

$8.2

$9.8

(1) Reflects preliminary statutory results as of September 30, 2022.

Capitalization

As of September 30, 2022:

  • Statutory combined total adjusted capital(1) ("TAC") decreased to approximately $8.0 billion, primarily due to a reduction in admitted deferred tax assets in the third quarter

  • Estimated combined RBC ratio(1) between 450% and 470%, which reflects the above-mentioned decrease in TAC, as well as capital requirements associated with continued growth in new business

  • Holding company liquid assets were approximately $1.1 billion

_______________

(1) Reflects preliminary statutory results as of September 30, 2022.

Earnings Conference Call

Brighthouse Financial will hold a conference call and audio webcast to discuss its financial results for the third quarter of 2022 at 8:00 a.m. Eastern Time on Tuesday, November 8, 2022. In connection with this call, the company has prepared a presentation for use with investors and other members of the investment community. This presentation is available on the Brighthouse Financial Investor Relations webpage at http://investor.brighthousefinancial.com.

To listen to the audio webcast via the internet and to access the related presentation, please visit the Brighthouse Financial Investor Relations webpage at http://investor.brighthousefinancial.com. To join the conference call via telephone as a participant, please register in advance at https://register.vevent.com/register/BIf03c16919949474a8738f2e33b9a119c.

A replay of the conference call will be made available until Friday, November 25, 2022, on the Brighthouse Financial Investor Relations webpage at http://investor.brighthousefinancial.com.

About Brighthouse Financial, Inc.

Brighthouse Financial, Inc. (Brighthouse Financial) (Nasdaq: BHF) is on a mission to help people achieve financial security. As one of the largest providers of annuities and life insurance in the U.S.,(1) we specialize in products designed to help people protect what they've earned and ensure it lasts. Learn more at brighthousefinancial.com.

(1) Ranked by 2021 admitted assets. Best's Review®: Top 200 U.S. Life/Health Insurers. AM Best, 2022.

Note Regarding Forward-Looking Statements

This news release and other oral or written statements that we make from time to time may contain information that includes or is based upon forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve substantial risks and uncertainties. We have tried, wherever possible, to identify such statements using words such as "anticipate," "estimate," "expect," "project," "may," "will," "could," "intend," "goal," "target," "guidance," "forecast," "preliminary," "objective," "continue," "aim," "plan," "believe" and other words and terms of similar meaning, or that are tied to future periods, in connection with a discussion of future operating or financial performance. In particular, these include, without limitation, statements relating to future actions, prospective services or products, financial projections, future performance or results of current and anticipated services or products, sales efforts, expenses, the outcome of contingencies such as legal proceedings, as well as trends in operating and financial results.

Any or all forward-looking statements may turn out to be wrong. They can be affected by inaccurate assumptions or by known or unknown risks and uncertainties. Many such factors will be important in determining the actual future results of Brighthouse Financial. These statements are based on current expectations and the current economic environment and involve a number of risks and uncertainties that are difficult to predict. These statements are not guarantees of future performance. Actual results could differ materially from those expressed or implied in the forward-looking statements due to a variety of known and unknown risks, uncertainties and other factors. Although it is not possible to identify all of these risks and factors, they include, among others: differences between actual experience and actuarial assumptions and the effectiveness of our actuarial models; higher risk management costs and exposure to increased market risk due to guarantees within certain of our products; the effectiveness of our variable annuity exposure risk management strategy and the impact of such strategy on volatility in our profitability measures and negative effects on our statutory capital; material differences from actual outcomes compared to the sensitivities calculated under certain scenarios and sensitivities that we may utilize in connection with our variable annuity risk management strategies; the impact of interest rates on our future ULSG policyholder obligations and net income volatility; the impact of the ongoing COVID-19 pandemic; the potential material adverse effect of changes in accounting standards, practices or policies applicable to us, including changes in the accounting for long-duration contracts; loss of business and other negative impacts resulting from a downgrade or a potential downgrade in our financial strength or credit ratings; the availability of reinsurance and the ability of the counterparties to our reinsurance or indemnification arrangements to perform their obligations thereunder; heightened competition, including with respect to service, product features, scale, price, actual or perceived financial strength, claims-paying ratings, credit ratings, e-business capabilities and name recognition; our ability to market and distribute our products through distribution channels; any failure of third parties to provide services we need, any failure of the practices and procedures of such third parties and any inability to obtain information or assistance we need from third parties; the ability of our subsidiaries to pay dividends to us, and our ability to pay dividends to our shareholders and repurchase our common stock; the risks associated with climate change; the adverse impact on liabilities for policyholder claims as a result of extreme mortality events; the impact of adverse capital and credit market conditions, including with respect to our ability to meet liquidity needs and access capital; the impact of economic conditions in the capital markets and the U.S. and global economy, as well as geo-political events, military actions or catastrophic events, on our investment portfolio, including on realized and unrealized losses and impairments, net investment spread and net investment income; the impact of events that adversely affect issuers, guarantors or collateral relating to our investments or our derivatives counterparties, on impairments, valuation allowances, reserves, net investment income and changes in unrealized gain or loss positions; the impact of changes in regulation and in supervisory and enforcement policies on our insurance business or other operations; the potential material negative tax impact of potential future tax legislation that could make some of our products less attractive to consumers; the effectiveness of our policies and procedures in managing risk; the loss or disclosure of confidential information, damage to our reputation and impairment of our ability to conduct business effectively as a result of any failure in cyber- or other information security systems; whether all or any portion of the tax consequences of our separation from MetLife, Inc. ("MetLife") are not as expected, leading to material additional taxes or material adverse consequences to tax attributes that impact us; the uncertainty of the outcome of any disputes with MetLife over tax-related or other matters and agreements or disagreements regarding MetLife’s or our obligations under our other agreements; and other factors described from time to time in documents that we file with the U.S. Securities and Exchange Commission (the "SEC").

For the reasons described above, we caution you against relying on any forward-looking statements, which should also be read in conjunction with the other cautionary statements included and the risks, uncertainties and other factors identified in our Annual Report on Form 10-K for the year ended December 31, 2021, particularly in the sections entitled "Risk Factors" and "Quantitative and Qualitative Disclosures About Market Risk," as well as in our other subsequent filings with the SEC. Further, any forward-looking statement speaks only as of the date on which it is made, and we undertake no obligation to update or revise any forward-looking statement to reflect events or circumstances after the date on which the statement is made or to reflect the occurrence of unanticipated events, except as otherwise may be required by law.

Non-GAAP and Other Financial Disclosures

Our definitions of non-GAAP and other financial measures may differ from those used by other companies.

Non-GAAP Financial Disclosures

We present certain measures of our performance that are not calculated in accordance with accounting principles generally accepted in the United States of America, also known as "GAAP." We believe that these non-GAAP financial measures enhance the understanding of our performance by the investor community by highlighting the results of operations and the underlying profitability drivers of our business.

The following non-GAAP financial measures, previously referred to as operating measures, should not be viewed as substitutes for the most directly comparable financial measures calculated in accordance with GAAP:

Non-GAAP financial measures:

Most directly comparable GAAP financial measures:

adjusted earnings

net income (loss) available to shareholders (1)

adjusted earnings, less notable items

net income (loss) available to shareholders (1)

adjusted revenues

revenues

adjusted expenses

expenses

adjusted earnings per common share

earnings per common share, diluted (1)

adjusted earnings per common share, less notable items

earnings per common share, diluted (1)

adjusted return on common equity

return on common equity (2)

adjusted return on common equity, less notable items

return on common equity (2)

adjusted net investment income

net investment income

__________________

(1)

Brighthouse uses net income (loss) available to shareholders to refer to net income (loss) available to Brighthouse Financial, Inc.'s common shareholders, and earnings per common share, diluted to refer to net income (loss) available to shareholders per common share.

(2)

Brighthouse uses return on common equity to refer to return on Brighthouse Financial, Inc.'s common stockholders' equity.

Reconciliations to the most directly comparable historical GAAP measures are included for those measures which are presented herein. Reconciliations of these non-GAAP financial measures to the most directly comparable GAAP financial measures are not accessible on a forward-looking basis because we believe it is not possible without unreasonable efforts to provide other than a range of net investment gains and losses and net derivative gains and losses, which can fluctuate significantly within or outside the range and from period to period and may have a material impact on net income (loss) available to shareholders.

Adjusted Earnings, Adjusted Revenues and Adjusted Expenses

Adjusted earnings is a financial measure used by management to evaluate performance and facilitate comparisons to industry results. This financial measure, which may be positive or negative, focuses on our primary businesses by excluding the impact of market volatility, which could distort trends.

Adjusted earnings reflects adjusted revenues less (i) adjusted expenses, (ii) provision for income tax expense (benefit), (iii) net income (loss) attributable to noncontrolling interests and (iv) preferred stock dividends. Provided below are the adjustments to GAAP revenues and GAAP expenses used to calculate adjusted revenues and adjusted expenses, respectively.

The following are significant items excluded from total revenues in calculating the adjusted revenues component of adjusted earnings:

  • Net investment gains (losses);

  • Net derivative gains (losses) ("NDGL") except earned income and amortization of premium on derivatives that are hedges of investments or that are used to replicate certain investments, but do not qualify for hedge accounting treatment ("Investment Hedge Adjustments"); and

  • Certain variable annuity GMIB fees ("GMIB Fees").

The following are significant items excluded from total expenses in calculating the adjusted expenses component of adjusted earnings:

  • Amounts associated with benefits related to GMIBs ("GMIB Costs");

  • Amounts associated with periodic crediting rate adjustments based on the total return of a contractually referenced pool of assets ("Market Value Adjustments"); and

  • Amortization of DAC and value of business acquired ("VOBA") related to (i) net investment gains (losses), (ii) net derivative gains (losses) and (iii) GMIB Fees and GMIB Costs.

The tax impact of the adjustments discussed above is calculated net of the statutory tax rate, which could differ from our effective tax rate.

Consistent with GAAP guidance for segment reporting, adjusted earnings is also our GAAP measure of segment performance.

Adjusted Earnings per Common Share and Adjusted Return on Common Equity

Adjusted earnings per common share and adjusted return on common equity are measures used by management to evaluate the execution of our business strategy and align such strategy with our shareholders' interests.

Adjusted earnings per common share is defined as adjusted earnings for the period divided by the weighted average number of fully diluted shares of common stock outstanding for the period. The weighted average common shares outstanding used to calculate adjusted earnings per share will differ from such shares used to calculate diluted net income (loss) available to shareholders per common share when the inclusion of dilutive shares has an anti-dilutive effect for one calculation but not for the other.

Adjusted return on common equity is defined as total annual adjusted earnings on a four quarter trailing basis, divided by the simple average of the most recent five quarters of total Brighthouse Financial, Inc.'s common stockholders' equity, excluding AOCI.

Adjusted Net Investment Income

We present adjusted net investment income to measure our performance for management purposes, and we believe it enhances the understanding of our investment portfolio results. Adjusted net investment income represents net investment income, including Investment Hedge Adjustments.

Other Financial Disclosures

Corporate Expenses

Corporate expenses includes functional department expenses, public company expenses, certain investment expenses, retirement funding and incentive compensation; and excludes establishment costs.

Notable items

Certain of the non-GAAP measures described above may be presented further adjusted to exclude notable items. Notable items reflect the unfavorable (favorable) after-tax impact on our results of certain unanticipated items and events, as well as certain items and events that were anticipated, such as establishment costs. The presentation of notable items and non-GAAP measures, less notable items is intended to help investors better understand our results and to evaluate and forecast those results.

Book Value per Common Share and Book Value per Common Share, excluding AOCI

Brighthouse uses the term "book value" to refer to "Brighthouse Financial, Inc.'s common stockholders' equity, including AOCI." Book value per common share is defined as ending Brighthouse Financial, Inc.'s common stockholders' equity, including AOCI, divided by ending common shares outstanding. Book value per common share, excluding AOCI, is defined as ending Brighthouse Financial, Inc.'s common stockholders' equity, excluding AOCI, divided by ending common shares outstanding.

CTE98

CTE98 is defined as the amount of assets required to satisfy contract holder obligations across market environments in the average of the worst two percent of a set of capital market scenarios over the life of the contracts.

Holding Company Liquid Assets

Holding company liquid assets include liquid assets in Brighthouse Financial, Inc., Brighthouse Holdings, LLC, and Brighthouse Services, LLC. Liquid assets are comprised of cash and cash equivalents, short-term investments and publicly-traded securities, excluding assets that are pledged or otherwise committed. Assets pledged or otherwise committed include assets held in trust.

Total Adjusted Capital

Total adjusted capital primarily consists of statutory capital and surplus, as well as the statutory asset valuation reserve. When referred to as "combined," represents that of our insurance subsidiaries as a whole.

Sales

Life insurance sales consist of 100 percent of annualized new premium for term life, first-year paid premium for whole life, universal life, and variable universal life, and total paid premium for indexed universal life. We exclude company-sponsored internal exchanges, corporate-owned life insurance, bank-owned life insurance, and private placement variable universal life.

Annuity sales consist of 100 percent of direct statutory premiums, except for fixed index annuity sales, which represents 100 percent of gross sales on directly written business and the proportion of assumed gross sales under reinsurance agreements. Annuity sales exclude certain internal exchanges. These sales statistics do not correspond to revenues under GAAP, but are used as relevant measures of business activity.

Net Investment Income Yield

Similar to adjusted net investment income, we present net investment income yields as a performance measure we believe enhances the understanding of our investment portfolio results. Net investment income yields are calculated on adjusted net investment income as a percentage of average quarterly asset carrying values. Asset carrying values exclude unrealized gains (losses), collateral received in connection with our securities lending program, freestanding derivative assets and collateral received from derivative counterparties. Investment fee and expense yields are calculated as investment fees and expenses as a percentage of average quarterly asset estimated fair values. Asset estimated fair values exclude collateral received in connection with our securities lending program, freestanding derivative assets and collateral received from derivative counterparties.

Normalized Statutory Earnings (Loss)

Normalized statutory earnings (loss) is used by management to measure our insurance companies’ ability to pay future distributions and is reflective of whether our hedging program functions as intended. Normalized statutory earnings (loss) is calculated as statutory pre-tax net gain (loss) from operations adjusted for the favorable or unfavorable impacts of (i) net realized capital gains (losses), (ii) the change in total asset requirement at CTE98, net of the change in our variable annuity reserves, and (iii) unrealized gains (losses) associated with our variable annuities and other equity risk management strategies. Normalized statutory earnings (loss) may be further adjusted for certain unanticipated items that impacted our results in order to help management and investors better understand, evaluate and forecast those results.

Risk-Based Capital Ratio

The risk-based capital ratio is a method of measuring an insurance company’s capital, taking into consideration its relative size and risk profile, in order to ensure compliance with minimum regulatory capital requirements set by the National Association of Insurance Commissioners. When referred to as "combined," represents that of our insurance subsidiaries as a whole. The reporting of our combined risk-based capital ratio is not intended for the purpose of ranking any insurance company or for use in connection with any marketing, advertising or promotional activities.

Condensed Statements of Operations (Unaudited, in millions)

For the Three Months Ended

Revenues

September 30,

2022

June 30,

2022

September 30,

2021

Premiums

$162

$167

$193

Universal life and investment-type product policy fees

783

784

881

Net investment income

877

1,061

1,281

Other revenues

121

118

117

Revenues before NIGL and NDGL

1,943

2,130

2,472

Net investment gains (losses)

(45)

(66)

(16)

Net derivative gains (losses)

(416)

1,733

56

Total revenues

$1,482

$3,797

$2,512

Expenses

Policyholder benefits and claims

$1,246

$1,108

$1,112

Interest credited to policyholder account balances

430

319

413

Amortization of DAC and VOBA

179

566

(82)

Interest expense on debt

38

38

41

Other expenses

457

553

538

Total expenses

2,350

2,584

2,022

Income (loss) before provision for income tax

(868)

1,213

490

Provision for income tax expense (benefit)

(193)

230

105

Net income (loss)

(675)

983

385

Less: Net income (loss) attributable to noncontrolling interests

2

2

Net income (loss) attributable to Brighthouse Financial, Inc.

(677)

983

383

Less: Preferred stock dividends

25

26

22

Net income (loss) available to Brighthouse Financial, Inc.’s common shareholders

$(702)

$957

$361

Condensed Balance Sheets (Unaudited, in millions)

As of

ASSETS

September 30,

2022

June 30,

2022

September 30,

2021

Investments:

Fixed maturity securities available-for-sale

$75,271

$78,606

$87,074

Equity securities

100

96

90

Mortgage loans

22,089

21,508

18,267

Policy loans

1,274

1,277

1,264

Limited partnerships and limited liability companies

4,607

4,683

3,959

Short-term investments

1,130

920

1,892

Other invested assets

4,033

3,345

2,774

Total investments

108,504

110,435

115,320

Cash and cash equivalents

4,793

5,071

4,108

Accrued investment income

909

852

764

Reinsurance recoverables

17,116

15,649

15,339

Premiums and other receivables

761

993

959

DAC and VOBA

5,639

5,434

5,356

Current income tax recoverable

18

18

Deferred income tax asset

1,619

471

Other assets

446

445

484

Separate account assets

81,836

88,843

112,361

Total assets

$221,641

$228,211

$254,691

LIABILITIES AND EQUITY

Liabilities

Future policy benefits

$41,786

$41,142

$43,795

Policyholder account balances

71,323

68,293

63,748

Other policy-related balances

3,364

3,273

3,406

Payables for collateral under securities loaned and other transactions

6,532

6,675

5,639

Long-term debt

3,156

3,157

3,436

Current income tax payable

148

Deferred income tax liability

1,120

Other liabilities

7,765

6,572

4,942

Separate account liabilities

81,836

88,843

112,361

Total liabilities

215,762

217,955

238,595

Equity

Preferred stock, at par value

Common stock, at par value

1

1

1

Additional paid-in capital

14,095

14,113

13,830

Retained earnings (deficit)

304

981

(705)

Treasury stock

(1,949)

(1,813)

(1,385)

Accumulated other comprehensive income (loss)

(6,637)

(3,091)

4,290

Total Brighthouse Financial, Inc.’s stockholders’ equity

5,814

10,191

16,031

Noncontrolling interests

65

65

65

Total equity

5,879

10,256

16,096

Total liabilities and equity

$221,641

$228,211

$254,691

Reconciliation of Net Income (Loss) Available to Shareholders to Adjusted Earnings and Adjusted Earnings, Less Notable Items, and Reconciliation of Net Income (Loss) Available to Shareholders per Common Share to Adjusted Earnings per Common Share and Adjusted Earnings, Less Notable Items per Common Share (Unaudited, in millions except per share data)

For the Three Months Ended

ADJUSTED EARNINGS, LESS NOTABLE ITEMS

September 30,

2022

June 30,

2022

September 30,

2021

Net income (loss) available to shareholders

$(702)

$957

$361

Less: Net investment gains (losses)

(45)

(66)

(16)

Less: Net derivative gains (losses), excluding investment hedge adjustments

(439)

1,724

50

Less: GMIB Fees and GMIB Costs

(336)

(136)

(83)

Less: Amortization of DAC and VOBA

(212)

(371)

(64)

Less: Market value adjustments and other

21

31

2

Less: Provision for income tax (expense) benefit on reconciling adjustments

212

(249)

22

Adjusted earnings

97

24

450

Less: Notable items

100

(223)

(64)

Adjusted earnings, less notable items

$(3)

$247

$514

ADJUSTED EARNINGS, LESS NOTABLE ITEMS PER COMMON SHARE (1)

Net income (loss) available to shareholders per common share

$(9.82)

$12.77

$4.34

Less: Net investment gains (losses)

(0.63)

(0.88)

(0.19)

Less: Net derivative gains (losses), excluding investment hedge adjustments

(6.14)

23.00

0.60

Less: GMIB Fees and GMIB Costs

(4.70)

(1.81)

(1.00)

Less: Amortization of DAC and VOBA

(2.96)

(4.95)

(0.77)

Less: Market value adjustments and other

0.29

0.41

0.02

Less: Provision for income tax (expense) benefit on reconciling adjustments

2.96

(3.32)

0.26

Less: Impact of inclusion of dilutive shares

0.01

Adjusted earnings per common share

1.35

0.33

5.41

Less: Notable items

1.39

(2.97)

(0.77)

Adjusted earnings, less notable items per common share

$(0.04)

$3.29

$6.17

(1) Per share calculations are on a diluted basis and may not recalculate or foot due to rounding. For loss periods, dilutive shares were not included in the calculation as inclusion of such shares would have an anti-dilutive effect. See Non-GAAP and Other Financial Disclosures discussion in this news release.

Reconciliation of Net Investment Income to Adjusted Net Investment Income (Unaudited, in millions)

For the Three Months Ended

September 30,

2022

June 30,

2022

September 30,

2021

Net investment income

$877

$1,061

$1,281

Less: Investment hedge adjustments

(23)

(9)

(6)

Adjusted net investment income

$900

$1,070

$1,287

Notable Items (Unaudited, in millions)

For the Three Months Ended

NOTABLE ITEMS IMPACTING ADJUSTED EARNINGS

September 30,

2022

June 30,

2022

September 30,

2021

Actuarial items and other insurance adjustments

$(117)

$214

$44

Establishment costs

17

9

20

Total notable items (1)

$(100)

$223

$64

NOTABLE ITEMS BY SEGMENT AND CORPORATE & OTHER

Annuities

$45

$14

$(42)

Life

5

2

(3)

Run-off

(128)

198

89

Corporate & Other

(22)

9

20

Total notable items (1)

$(100)

$223

$64

(1) See Non-GAAP and Other Financial Disclosures discussion in this news release.

View source version on businesswire.com: https://www.businesswire.com/news/home/20221107005652/en/

Contacts

FOR INVESTORS
Dana Amante
(980) 949-3073
damante@brighthousefinancial.com

FOR MEDIA
Deon Roberts
(980) 949-3071
deon.roberts@brighthousefinancial.com